Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pizzolo

Showing results (201-210 of 210) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 210 results.
Blood|January 11, 2000
Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphomaR Chiarle, L M Budel, J Skolnik, et al.
Blood|November 15, 1996
p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene functionM Chilosi, C Doglioni, A Magalini, et al.
American Journal of Hematology|January 26, 2011
Alpha- and beta-synucleins are new diagnostic tools for acute erythroid leukemia and acute megakaryoblastic leukemiaRobert W Maitta, Lucia R Wolgast, Qing Wang, et al.
Leukemia|November 4, 2006
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factorR Zanotti, A Ambrosetti, M Lestani, et al.
Biochemical and Biophysical Research Communications|March 17, 1997
Cellular changes and induction of apoptosis in human promyelocytic HL-60 cells infected with the agent of human granulocytic ehrlichiosis (HGE)T C Hsieh, M E Aguero-Rosenfeld, J M Wu, et al.
British Journal of Haematology|June 2, 2007
High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphomaC Tecchio, G Nadali, P Scapini, et al.
Haematologica|March 20, 2001
Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphomaT P Vassilakopoulos, G Nadali, M K Angelopoulou, et al.
Clinical and Experimental Immunology|May 24, 2014
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplantE Mimiola, O Marini, O Perbellini, et al.
British Journal of Cancer|January 22, 2004
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-BG Todeschini, S Secchi, E Morra, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 6, 2007
beta(2)-microglobulin in Hodgkin's lymphoma: prognostic significance in patients treated with ABVD or equivalent regimensT P Vassilakopoulos, G Nadali, M K Angelopoulou, et al.
Pageof 21

Showing results (201-210 of 210) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 210 results.
Blood|January 11, 2000
Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphomaR Chiarle, L M Budel, J Skolnik, et al.
Blood|November 15, 1996
p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene functionM Chilosi, C Doglioni, A Magalini, et al.
American Journal of Hematology|January 26, 2011
Alpha- and beta-synucleins are new diagnostic tools for acute erythroid leukemia and acute megakaryoblastic leukemiaRobert W Maitta, Lucia R Wolgast, Qing Wang, et al.
Leukemia|November 4, 2006
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factorR Zanotti, A Ambrosetti, M Lestani, et al.
Biochemical and Biophysical Research Communications|March 17, 1997
Cellular changes and induction of apoptosis in human promyelocytic HL-60 cells infected with the agent of human granulocytic ehrlichiosis (HGE)T C Hsieh, M E Aguero-Rosenfeld, J M Wu, et al.
British Journal of Haematology|June 2, 2007
High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphomaC Tecchio, G Nadali, P Scapini, et al.
Haematologica|March 20, 2001
Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphomaT P Vassilakopoulos, G Nadali, M K Angelopoulou, et al.
Clinical and Experimental Immunology|May 24, 2014
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplantE Mimiola, O Marini, O Perbellini, et al.
British Journal of Cancer|January 22, 2004
Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-BG Todeschini, S Secchi, E Morra, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|March 6, 2007
beta(2)-microglobulin in Hodgkin's lymphoma: prognostic significance in patients treated with ABVD or equivalent regimensT P Vassilakopoulos, G Nadali, M K Angelopoulou, et al.
Pageof 21